ArticleOncology reports2024

Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the MET pathway in glioblastoma cells.

Ming-Shan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.